about
Current and emerging treatment strategies for Duchenne muscular dystrophyDuchenne Muscular Dystrophy: From Diagnosis to TherapyThe quasi-parallel lives of satellite cells and atrophying muscleThe TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and diseaseCurrent understanding of molecular pathology and treatment of cardiomyopathy in duchenne muscular dystrophyTWEAK/Fn14, a pathway and novel therapeutic target in myotonic dystrophy.Biophysical characterization of naturally occurring titin M10 mutationsDystrophic Cardiomyopathy-Potential Role of Calcium in Pathogenesis, Treatment and Novel TherapiesA Novel NF-κB Inhibitor, Edasalonexent (CAT-1004), in Development as a Disease-Modifying Treatment for Patients With Duchenne Muscular Dystrophy: Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics in Adult SubjectsProteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy.Muscular response to the first three months of deflazacort treatment in boys with Duchenne muscular dystrophyPharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trialsMonoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies.Life or death by NFκB, Losartan promotes survival in dy2J/dy2J mouse of MDC1A.Dysregulated mechanisms underlying Duchenne muscular dystrophy from co-expression network preservation analysisCavin4b/Murcb Is Required for Skeletal Muscle Development and Function in Zebrafish.Fyn Activation of mTORC1 Stimulates the IRE1α-JNK Pathway, Leading to Cell DeathIdentification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics.Muscle Satellite Cell Protein Teneurin-4 Regulates Differentiation During Muscle Regeneration.Toll-like receptor signalling in regenerative myogenesis: friend and foe.Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles.Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Inflammation and Fibrosis of Skeletal MusclesDistinct roles of TRAF6 at early and late stages of muscle pathology in the mdx model of Duchenne muscular dystrophy.Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease.Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis.Oxidative stress in muscular dystrophy: from generic evidence to specific sources and targets.Therapeutic potential of matrix metalloproteinases in Duchenne muscular dystrophy.Drug Discovery of Therapies for Duchenne Muscular Dystrophy.Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis.Conditional knockout of pik3c3 causes a murine muscular dystrophy.Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection.Co-administration of deflazacort and doxycycline: a potential pharmacotherapy for Duchenne muscular dystrophy.Influence of Botulinumtoxin A on the Expression of Adult MyHC Isoforms in the Masticatory Muscles in Dystrophin-Deficient Mice (Mdx-Mice).Dystrophic phenotype improvement in the diaphragm muscle of mdx mice by diacerhein.Liprin-α-1 is a novel component of the murine neuromuscular junction and is involved in the organization of the postsynaptic machinery.What Can be Learned from the Time Course of Changes in Low-Frequency Stimulated Muscle?Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury.ER stress in skeletal muscle remodeling and myopathies.Dystrophin gene expression and intracellular calcium changes in the giant freshwater prawn, Macrobrachium rosenbergii, in response to white spot symptom disease infection.
P2860
Q26741535-C002849A-D7D2-42AF-8E2A-3D7B63E9D485Q26784259-4AD65084-53C9-4F1E-90DC-6A73830CFA92Q26800207-71134DBA-1BED-4077-8BA6-64B3CFDAF7B1Q26999255-456EB491-81F9-49C2-B48E-5FB5D859FB02Q28082625-71E8A78C-9971-4290-B0BB-C0973A0D50D9Q30301119-102F60C7-9A59-46E4-B8F6-D84CBD484FACQ30372392-C7547E81-4252-4E28-936D-D42DA7EE3D98Q33608478-4653D543-7F5F-41A7-B269-8DB79EEC20EFQ33625958-7D3163BF-CBA2-401A-97AD-474205232198Q33675040-B73242E3-2B72-439D-819C-2AC190C1BADCQ33856905-51EFB80E-BEEA-43A2-9050-AB85E48FD150Q34152280-8B16181C-6014-4A1C-B45B-65E5DBC92D27Q34266732-CCCAFD00-FDF2-412E-AFBF-CEEB95CCF2E1Q35274694-A9316FAD-4286-4C02-9BBC-E92AA504A255Q35583817-D9B1AE63-58E1-4DCA-AC18-BC37F22A9DE4Q36050192-8BB40421-58EC-47AA-B6A6-0ECD139800D5Q36139815-F5C55638-67C0-4539-BB1E-DE2B93FD11A4Q36305436-EB27B136-0656-46B6-AFB3-6690B8CCA285Q36554338-BCBDB008-0F64-4E9F-BF6A-FF6F7A55BC11Q37119640-2B127F49-435E-4420-A9ED-876D78F0B276Q37566483-16354F88-DF2E-4614-AF47-8C1910B50CEAQ37589790-4831DABD-6D9D-46B5-82FB-477508CCF5D0Q37593034-C8F8075C-A1DA-4994-B01E-CAB4D6BE5973Q37734762-4AEAF799-2B23-4FFC-973C-58ABA16297C6Q38135328-0D9931A1-E5A8-48AC-9471-9ABB14C04F84Q38195206-F3BFDB2B-E082-45F4-BD92-AD505BF46587Q38264461-7B90B2F4-A697-4091-A52B-1CDF660910F9Q38480698-770A3889-34EB-44AD-A0FE-06B90042A4E6Q39033229-AD77A996-D9EC-4E34-85FB-4F41085B0988Q40279285-CE8C117F-62D5-4235-8EDE-DDAF375FD4A7Q40820281-AD044A79-A2D5-42E7-BDC1-6910B8228DD8Q40955126-AEC0D2DE-8494-4B8B-BDD6-7DB0AA4AD534Q41096343-4D1CEFE1-25A6-4F67-A8F9-07BBE0E09CE0Q41282592-4542A93A-4D4F-474B-B87B-D80C0DC4A218Q41489936-2F10E05E-78F6-4044-9D1F-D6BAD00F088CQ42332564-A39A28ED-B7DF-4521-8F3F-B6E0EA0B2B09Q42363358-98544D0A-83F4-4A90-9217-4C1ACB396091Q44907195-453A1BA4-F835-4899-80F2-288B6FF427B5Q47295145-78723286-20E7-4C57-BA2F-5651B8C6D1C0Q47555655-F7FC6EB1-2300-4A43-9830-4F1AD9EE37D1
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Wasting mechanisms in muscular dystrophy.
@en
Wasting mechanisms in muscular dystrophy.
@nl
type
label
Wasting mechanisms in muscular dystrophy.
@en
Wasting mechanisms in muscular dystrophy.
@nl
prefLabel
Wasting mechanisms in muscular dystrophy.
@en
Wasting mechanisms in muscular dystrophy.
@nl
P2093
P2860
P1476
Wasting mechanisms in muscular dystrophy
@en
P2093
Jonghyun Shin
Marjan M Tajrishi
Yuji Ogura
P2860
P304
P356
10.1016/J.BIOCEL.2013.05.001
P50
P577
2013-05-11T00:00:00Z